Blood coagulation Flashcards
Haemostasis, porocesses that
1) stop haemorrhage
2) prevent haemorrhage
3) maintain blood flow
Primary haemostasis includes
secondary includes
1) vasoconstriction
2) haemostatic plug formation
Activation of clotting factors to form a thrombus
Haemostasis is carried out by which mechanisms
1) cellular= platelets
2) Humoral = coagulation
3) Tissue = vessels
Disordered haemostasis
Thrombosis- excess or innappriate clotting
1) Arterial caused by platelets
Coronary thormbosis, thrombotic stroke
2) Venous caused by coagulation
DVT and PE
Haemorrhage- excess or innappropriate bleeding
Trauma or bleeding diatheses
bleeding diatheses
tendency to suffer from a particular kind of disease- in this case bleeding.
e.g. haemophilia, von Willebrand disease
Virchow’s triad
3 causative factors of thrombosis:
1) Coagulation factors- humoral
2) Platelets (cellular)
3) Blood vessels
How do blood vessels contribute to blood control?
Produce vasoactive mediators and haemostatic agents
Vasospasm (vasoconstriction)
Coagulation cascade
Intrinsic pathway
XIIa (12)
XIIIa (8) + XIa (11)
Va (5) + IXa (9)
IIa (thrombin)
Ia (fibrin)
Extrinsic pathway
Initial damage
IIIa (3)
VIIa (7)
Xa (10)
IIa (thrombin)
I (fibrin)
Why is it phsiologically beneficial to have so many steps in the coagulataion cascade?
The more steps you have, the more control you have over it.
This is particulalry important where there is positive feedback and you don’t want to trigger this process in an unijured are
Fibrinolytic drug example
Alteplase
Examples of antiplatelet drugs
- Aspririn
- Clodidogrel
- Ticagrelor
- Tirofiban
Fibrinogen
Factor 1
Soluble glycoprotein synthesised by the liver
Heterohexamer (2x a chain and 2x B and 2x Y)
Acts as a bifunctional ligand for aIIbB3 integrin (glycoprotein IIb/IIIa) on platelets
Mostly found in plasma, some found in platelet granules
Target for drugs
Cross-links platelets –> aggregation
Fibrin
Factor Ia
Insoluble protein
Formed by action of thrombin on a and B chains of fibrinogen
Fibrinopeptide A and B
Spontaneously polymerizes –> forms fibrin clot–> coagulation
Entangle platelets, building up a spongy mass that gradually hardens and contracts to form the blood clot.
Hardening process stabilized by FXIII (fibrin-stabilizing factor)
As fibrin is formed it binds to thrombin- limiting the thrombin that is active
Fibrinogen –>?
Fibrinogen –> fibrin monomer–> finrin polymer –> fibrin fibril
Glycoprotein IIb/IIIa (integrin αIIbβ3)
Integrin complex found on platelets
Receptor for fibrinogen and von Willebrand factor
Aids in platelet activation
formed via calcium-dependent association of gpIIb and gpIIIa, a required step in normal platelet aggregation
Platelet activation by ADP (blocked by clodipogrel) causes conformtational change in integrin αIIbβ3 receptors to allow FII binding
Prothrombin
Factor II
Zymogen, soluble plasma protein
monomer
Vitamin k-dependant factor
10y-carboxyglutamate residues confer a strong negative charge which binds to Ca2+
Thrombin
Factor IIa
Active enzyme
Serine protease
Formed by action of FXa enhanced by FVa
Co-translationally modified in a vitamin k dependant reaction to have a Gla (inhibited by warfarin or vit K deficiency)
Activates many other factors, most notably fibrinogen by cleaving a and B chains
Target for gatran drugs
Engages in negative feedback
Made of a light and heavy chain
What does thrombin convert?
FXI–>XIa
FVIII–>VIIIa
FV–> Fva
fibrinogen –> fibrin
XIII–> XIIIa
Actiavtes platelets via proteinase activated receptors
Negative feedback mechanisms of thrombin
Bound to thrombomodulin (endothelial membrane protein), activates protein C, an inhibitor of the coagulation cascade.
Stimulates production of antithrombin (serine protease inhibitor)